Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. The Company is focused on the generic oncology injectable market in Europe, the United Kingdom (UK), and North America. The Company, through its subsidiaries, has entered into a license, manufacture, supply, marketing and distribution... see more

Bullboard (TSXV:WAVE)

View:
Comment by moneywinner1on Aug 13, 2020 10:31am

RE:RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4

It looks like good news is near , if closed tomorrow at 0.25-0.30 than watch on Monday 300-400 up to $1-$1.30
Comment by moneywinner1on Aug 13, 2020 8:53am

RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4

Pipeline https://www.waverleypharma.com/generic-product-pipeline.html WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other ...more  
Comment by Stocks2Goon Aug 12, 2020 1:55pm

RE:Volume & price up now for no reason

I think you will be back in the mid 20's very shortly.
Post by MidtownGuyon Aug 12, 2020 1:47pm

Volume & price up now for no reason

These stocks frustrate me to no end. But as a bagholder in the mid 20s, I'll take it.
Comment by ezemoneyon Aug 12, 2020 1:42pm

RE:Moving Back Up Now.

I took a tidy profit today.  This stock always comes back home in the low teens so I wait for it to come back home to Daddy.
Post by Stocks2Goon Aug 12, 2020 1:30pm

Moving Back Up Now.

I saw how fast this took off last time. Incredible.
Comment by Aman0808on Aug 12, 2020 1:02pm

RE:RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4

Thanks for posting this. Looking to get it and was hoping my understanding is correct that WAVE needs to wait until the patents expire and then they will have a sales pipeline of teh generic version ...more  
Comment by Investor62on Aug 12, 2020 11:17am

RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4

I just got the following from the company: Currently both of these products are still protected by patents until early next year (in most cases; varies country by country). However, by obtaining ...more  
Post by moneywinner1on Aug 12, 2020 8:54am

Today I should get my shares

Like I said before 0.15 I will be buying back  and expect news  to back to 0.30 , now I'm positive on fill and potential to make money 
Comment by 2skytracker2on Aug 11, 2020 6:12pm

RE:Tomorrow I will get filled

And I will buy more if it hits .15 GLTA
Comment by bullmarketson Aug 11, 2020 12:33pm

RE:Wave --new "Sedar" filing

They are a 300-500 million ( maybe more by now ) and would have had to pay more than current price. Between 25-35 cents would be my guess on cost. 
Comment by tankingfrankon Aug 11, 2020 10:35am

RE:Wave --new "Sedar" filing

thats good news, basically means there is no float.   why did they have to file?  they are under 10%
Post by Goldblackon Aug 11, 2020 10:17am

Wave --new "Sedar" filing

As of 07/31/2020 an institutional investor(MMCAP International inc) now owns 4.773 mil sharers or 8.84% of issued capital.GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities